Efficacy and tolerance of botulinum toxin injections after sacral nerve stimulation failure for idiopathic overactive bladder.
Maximilien BaronMarie-Aimée Perrouin-VerbeSandy LacombeFanny ParetLoïc Le NormandJean-Nicolas CornuPublished in: Neurourology and urodynamics (2020)
BoNT-A can be used in SNM nonresponders with a success rate of 43.4% but is associated with a high long-term discontinuation rate.
Keyphrases